Horizon Therapeutics Public Consensus Analyst Rating and Stock Price Forecast (2024) Analysts' Consensus Rating Hold Based on 1 Analyst Ratings Analysts' Consensus Price Target N/A TypeCurrent Forecast 1/4/23 to 1/4/241 Month Ago 12/5/22 to 12/5/233 Months Ago ...
trade at a trailing-12 P/E of 26.09, a forward P/E of 16.48 and a P/E to growth ratio of 2.71. The median Wall Street price target on the name is $45.50 with a high target of $67.00. Currently ticker boasts 8 ‘Buy’ endorsements, compared to 10 ’Holds...